OrbusNeich Medical Group Holdings Limited (HKG:6929)
Hong Kong · Delayed Price · Currency is HKD 3.700
+0.010 (0.27%)
Jul 31, 2026, 4:08 PM HKT
HKG:6929 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,046 | 2,982 | 3,096 | 5,837 | 7,284 | - | |
Market Cap Growth | -32.60% | -3.69% | -46.95% | -19.87% | - | - |
Enterprise Value | 1,379 | 1,074 | 1,128 | 3,792 | 6,124 | - |
Last Close Price | 3.70 | 3.51 | 3.43 | 6.30 | 7.87 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.36 | 9.15 | 10.04 | 16.58 | 50.52 | - |
Forward PE | 8.73 | 7.34 | 10.06 | 17.63 | - | - |
PS Ratio | 2.17 | 2.12 | 2.43 | 4.86 | 6.83 | - |
PB Ratio | 0.94 | 0.93 | 1.01 | 2.02 | 2.90 | - |
P/TBV Ratio | 0.99 | 0.97 | 1.06 | 2.14 | 2.92 | - |
P/FCF Ratio | 114.53 | 112.13 | 120.18 | 42.87 | 45.50 | - |
P/OCF Ratio | 20.04 | 19.62 | 30.40 | 32.44 | 39.87 | - |
PEG Ratio | 1.39 | 0.30 | 1.65 | 0.64 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.98 | 0.77 | 0.89 | 3.16 | 5.74 | - |
EV/EBITDA Ratio | 4.05 | 3.23 | 3.86 | 11.75 | 30.39 | - |
EV/EBIT Ratio | 4.66 | 3.51 | 4.17 | 12.33 | 32.87 | - |
EV/FCF Ratio | 51.86 | 40.40 | 43.79 | 27.85 | 38.25 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.37 |
Debt / EBITDA Ratio | 0.09 | 0.09 | 0.11 | 0.17 | 0.15 | 2.80 |
Debt / FCF Ratio | 1.15 | 1.15 | 1.27 | 0.43 | 0.20 | 3.52 |
Net Debt / Equity Ratio | -0.52 | -0.52 | -0.62 | -0.67 | -0.76 | -0.59 |
Net Debt / EBITDA Ratio | -5.03 | -5.03 | -6.51 | -6.02 | -9.46 | -4.75 |
Net Debt / FCF Ratio | -63.00 | -63.00 | -73.81 | -14.27 | -11.90 | -5.64 |
Asset Turnover | 0.41 | 0.41 | 0.39 | 0.40 | 0.44 | 0.63 |
Inventory Turnover | 0.94 | 0.94 | 1.01 | 1.34 | 1.51 | 1.18 |
Quick Ratio | 8.41 | 8.41 | 9.83 | 8.49 | 11.89 | 12.41 |
Current Ratio | 10.54 | 10.54 | 11.77 | 9.77 | 13.20 | 14.31 |
Return on Equity (ROE) | 10.40% | 10.40% | 10.43% | 13.03% | 7.31% | -4.08% |
Return on Assets (ROA) | 5.56% | 5.56% | 5.17% | 6.46% | 4.82% | 6.88% |
Return on Invested Capital (ROIC) | 17.66% | 20.16% | 24.21% | 35.95% | 26.56% | 28.25% |
Return on Capital Employed (ROCE) | 9.40% | 9.40% | 8.70% | 10.50% | 7.30% | 8.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 10.71% | 10.94% | 9.96% | 6.03% | 1.98% | - |
FCF Yield | 0.87% | 0.89% | 0.83% | 2.33% | 2.20% | - |
Dividend Yield | 3.26% | 3.41% | 2.90% | 1.59% | - | - |
Payout Ratio | 63.36% | 63.36% | 26.73% | - | - | - |
Buyback Yield / Dilution | 0.09% | 0.09% | 0.80% | -7.29% | -34.58% | - |
Total Shareholder Return | 3.36% | 3.50% | 3.71% | -5.70% | -34.58% | - |